Ilika Stereax device sales don’t have to wait till end of approval period (VIDEO)

Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk Interviews to discuss an update its on trading, Stereax® manufacturing, and Goliath product development.

Graeme addresses some concerns around the weighting now to medical devices where commercial sales are set to commence at the end of the (H2/2023) period, the visible lack of contracts, the interest Ilika is getting for Goliath, its strategic partners and whether it would it be better to complete the scale up and then look to spin or sell that part of the business.

Ilika is a pioneer in solid state battery technology, enabling solutions for applications such as Industrial IoT, MedTech, EV and Consumer Electronics.

You might also enjoy reading  Ilika expecting OEM investment in 100MWh or even 200MWh line (VIDEO)
Find more news, interviews, share price & company profile here for:
Ilika

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Ilika Stereax device sales don’t have to wait till end of approval period (VIDEO)

Other Interviews

More News

Ask your questions

Do you have questions you’d like to ask this company, get in touch and we’ll ask them for you.   

I have questions